Neoplasia (New York, N.Y.) - JoVE Visualize

Showing results (51-60 of 2,749) with videos related to

Pageof 275

Sort By:

Neoplasia (New York, N.Y.)|June 9, 2021

Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomasKotaro Sato, Kshitij Parag-Sharma, Masahiko Terajima, et al.

Neoplasia (New York, N.Y.)|January 10, 2021

TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganizationMarkus A Brown, Gabrielle A Dotson, Scott Ronquist, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma CellsJair Bar, Mohamed S Hasim, Tabassom Baghai, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisEunsohl Lee, Jingcheng Wang, Kenji Yumoto, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic SubclusterStephanie M J Fliedner, Uma Shankavaram, Geena Marzouca, et al.

Neoplasia (New York, N.Y.)|June 6, 2017

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor MicroenvironmentMelanie Mediavilla-Varela, Julio Castro, Alberto Chiappori, et al.

Neoplasia (New York, N.Y.)|June 8, 2017

Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma ModelDong Ju Son, Yu Yeon Jung, Mi Hee Park, et al.

Neoplasia (New York, N.Y.)|June 14, 2017

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.

Neoplasia (New York, N.Y.)|October 27, 2021

CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activationZheng Wang, Mohit Hulsurkar, Lijuan Zhuo, et al.

Neoplasia (New York, N.Y.)|October 7, 2021

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurabilityJuan C L Alfonso, G Daniel Grass, Eric Welsh, et al.

Pageof 275

Showing results (51-60 of 2,749) with videos related to

Sort By:

Pageof 275

Neoplasia (New York, N.Y.)|June 9, 2021

Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomasKotaro Sato, Kshitij Parag-Sharma, Masahiko Terajima, et al.

Neoplasia (New York, N.Y.)|January 10, 2021

TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganizationMarkus A Brown, Gabrielle A Dotson, Scott Ronquist, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma CellsJair Bar, Mohamed S Hasim, Tabassom Baghai, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisEunsohl Lee, Jingcheng Wang, Kenji Yumoto, et al.

Neoplasia (New York, N.Y.)|September 24, 2016

Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic SubclusterStephanie M J Fliedner, Uma Shankavaram, Geena Marzouca, et al.

Neoplasia (New York, N.Y.)|June 6, 2017

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor MicroenvironmentMelanie Mediavilla-Varela, Julio Castro, Alberto Chiappori, et al.

Neoplasia (New York, N.Y.)|June 8, 2017

Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma ModelDong Ju Son, Yu Yeon Jung, Mi Hee Park, et al.

Neoplasia (New York, N.Y.)|June 14, 2017

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.

Neoplasia (New York, N.Y.)|October 27, 2021

CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activationZheng Wang, Mohit Hulsurkar, Lijuan Zhuo, et al.

Neoplasia (New York, N.Y.)|October 7, 2021

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurabilityJuan C L Alfonso, G Daniel Grass, Eric Welsh, et al.

Pageof 275